2:00 PM – 3:45 PM
2:00 PM – 3:45 PM
JOINT ISHLT/ABTO SYMPOSYMPOSIUM: Combining Experiences to SIUM: Combining Enhance Thoracic Organ Transplantation Worldwide Experiences (PACIFICA 3-5) to Enhance Thoracic Organ Primary Audience: ID 3:00 PM Heart Transplant and Chagas Secondary Audience: HF/HTX Transplantation Worldwide Disease: Lessons Learned After 30
JOINT ISHLT/ICCAC SYMPOSIUM: Faster, Higher, Stronger: Monitoring Exercise in Cyberspace
Secondary Audience: LF/LTX (PACIFICA 3-5)
Years of Experience Tania Mara Varejão Strabelli, Primary Audience: ID MD, Heart Institute São Paulo Secondary Audience: HF/HTX SESSION SUMMARY: This joint symposium with the Associação Brasileira de Transplante Medical School, the Sãoopportunity Paulo, Audience: LF/LTX of Organ Transplants) de ÓrgãosSecondary (ABTO: Brazilian Association will provide Brazil to exchange experiences between heart and lung transplant centers in Brazil and other centers around the world. Important topics regarding aspects of thoracic organ procurement 3:15 PM Chagas Disease and Heart FailSESSION SUMMARY Thishealthy joint symposium in different countries: and systems as well as the regional variations in disease burden ure Management in withbe the Associação Brasileira de Transwill discussed. plante de Órgãos (ABTO: Brazilian AssociaNon-Endemic Areas tion : Fernanda Silveira, MD and Paulo M. Pego-Fernandes, RicardoMD, La Hoz, CHAIRS PhDMD, of Organ Transplants) will provide the opUT Southwestern Medical Cenportunity to exchange USALessons 2:00 PM The Largestheart Public Kidney Program inter, theDallas, World:TX, What experiences between and lungTransplant transShould We and Learn to Improve Organ plant centers in Brazil other centersThoracic 3:30 PM Transplantation? 15-min Panel Discussion Osmar Medina Pestana, MD, Hospital do Rim e Hipertensão of around the Jose world. Important topics regardFederal de São Paulo, São Paulo, Brazil ing aspects Universidade of thoracic organ procurement in different countries and healthy systems 2:15well PMas the Few Potential Donors and One of the Largest (Lung) Transplant Systems of the as regional variations in disease World: How is it Possible? burden will be discussed. Jonathan Yeung, MD, Toronto General Hospital, Toronto, ON, Canada CHAIRS: Silvia V. Campos, MD and 2:30 PM Tuberculosis and Thoracic Organ Paulo M. Pego-Fernandes, MD, Transplantation: Pre- and Post-Transplant Management in Endemic Areas PhD Luis Fernando Aranha Camargo, MD, Hospital Israelita de Albert Einstein, São Largest Paulo, Brazil 2:00 PM The Public Kidney 2:45 PM
3:00 PM
3:15 PM 2:15 PM 3:30 PM
2:30 PM
2:45 PM
51
Transplant in theOrgan Transplantation: Pre- and Post-Transplant TuberculosisProgram and Thoracic World: What Lessons Should Areas Management in Non-Endemic We Learn to Improve Thoracic Amparo Sole, MD, Hospital Universitario La Fe, Valencia, Spain Organ Transplantation? HeartOsmar Transplant and Chagas Disease: Lessons Learned After 30 Years of Jose Medina Pestana, Experience MD, Hospital do Rim e Tania Mara Varejão Strabelli, MD, Heart Institute São Paulo Medical School, Hipertensão of Universidade São Paulo, Federal de Brazil São Paulo, São Paulo, Brazil Chagas Disease and Heart Failure Management in Non-Endemic Areas Ricardo La Hoz, MD, UT Southwestern Medical Center, Dallas, TX, USA Few Potential Donors and One of the Largest (Lung) Transplant 15-min Panel Discussion Systems of the World: How is it Possible? Jonathan Yeung, MD, Toronto General Hospital, Toronto, ON, Canada Tuberculosis and Thoracic Organ Transplantation: Pre- and Post-Transplant Management in Endemic Areas Luis Fernando Aranha Camargo, MD, Hospital Israelita de Albert Einstein, São Paulo, Brazil Tuberculosis and Thoracic Organ Transplantation: Pre- and Post-Transplant Management in Non-Endemic Areas Amparo Sole, MD, Hospital Universitario La Fe, Valencia, Spain
(PACIFICA 6) Primary Audience: MCS Secondary Audience: NHSAH
SESSION SUMMARY: Patient and healthcare provider partnerships can enhance patient outcomes. Remote care support and monitoring of MCS patients can improve patient independence and positively impact patient care. This joint symposium with the International Consortium of Circulatory Assist Clinicians (ICCAC) will discuss integration of self-care strategies, educational preparation, new technologies maximizing MCS patient management, strategies to reduce morbidity and mortality, the future of MCS support, and challenges and opportunities that advancing technology poses to current practice. CHAIRS:
Peggy S. Blood, RN, MSN and Simon Maltais, MD, PhD
2:00 PM
Under Pressure: Continuous Pulmonary Artery Monitoring and LVAD Finn Gustafsson, MD, PhD, Rigshospitalet, Copenhagen, Denmark
2:15 PM
Q&A
2:20 PM
Care Anywhere: Remote Patient Monitoring Michele C. Kassemos, BSN, UCSF Medical Center, San Francisco, CA, USA
2:35 PM
Q&A
2:40 PM
There’s an App for That: Preparing the EMS Thomas Schloeglhofer, MSc, Medical University of Vienna, Vienna, Austria
2:55 PM
Q&A
3:00 PM
Frailty and Exercise Tolerance: How Are They Related? Kavitha Muthiah, MBchB, PhD, St. Vincent’s Hospital, Sydney, Australia
3:15 PM
Q&A
3:20 PM
Let the Pacer Do the Work! Conduction Abnormalities in Heart Failure and Their Role in Exercise During VAD Support Van-Khue Ton, MD, PhD, University of Maryland School of Medicine, Baltimore, MD, USA
3:35 PM
Q&A